ISDS Case Map
India
Time for cost-benefit analysis of all free-trade deals
Dhaka has decided to protest the New Delhi's action relating to allegation of dumping jute goods and hydrogen peroxide (H2O2) by Bangladesh, officials have said.
Any government to sign an agreement would necessitate a better feasibility study report that is more holistic in nature.
As negotiations for a Broad-Based Bilateral Trade and Investment Agreement with the European Union is heading nowhere, India should press for a separate Free Trade Agreement with Britain
Two UAE firms are claiming Rs 5 lakh crore ($85billion) as compensation, perhaps the highest arbitration demand in India's history.
Implications of the TPP on the Indian pharma industry might not be entirely clear yet. But there is a need for India to engage in the debate of trade deals and public interest.
The US government has again pushed India to expedite negotiations on the proposed Bilateral Investment Treaty (BIT).
So far, the NDA government has been a mute spectator to the US pharma strategy of forcing Indian generics manufacturers to produce only what is required for Indian consumers and abandon the export of cheap drugs to Africa
The United States International Trade Commission (USITC) has published a report on IPR policy transparency by India’s new government
India has raised its pitch for greater market access for professionals in the proposed regional comprehensive economic partnership (RCEP)
